Shares of Insmed, Inc. (NASDAQ:INSM – Get Free Report) have been assigned an average rating of “Buy” from the twenty-five ratings firms that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, twenty-two have given a buy rating and two have assigned a strong buy rating to […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.